NIP
BHVN
Nicholas Investment Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-137,306
| Closed | -$20M | – | 209 |
|
|
2022
Q2 | $20M | Sell |
137,306
-38,977
| -22% | -$5.68M | 1.89% | 4 |
|
|
2022
Q1 | $20.9M | Sell |
176,283
-50,588
| -22% | -$6M | 1.49% | 16 |
|
|
2021
Q4 | $31.3M | Buy |
226,871
+24,966
| +12% | +$3.44M | 1.98% | 4 |
|
|
2021
Q3 | $28M | Sell |
201,905
-161,803
| -44% | -$22.5M | 2.05% | 2 |
|
|
2021
Q2 | $35.3M | Sell |
363,708
-11,946
| -3% | -$1.16M | 2.21% | 1 |
|
|
2021
Q1 | $25.7M | Buy |
375,654
+105,292
| +39% | +$7.2M | 1.79% | 4 |
|
|
2020
Q4 | $23.2M | Buy |
270,362
+18,416
| +7% | +$1.58M | 1.79% | 9 |
|
|
2020
Q3 | $16.4M | Buy |
251,946
+192,988
| +327% | +$12.5M | 1.77% | 12 |
|
|
2020
Q2 | $4.31M | Sell |
58,958
-101,553
| -63% | -$7.42M | 0.87% | 25 |
|
|
2020
Q1 | $5.46M | Buy |
160,511
+16,794
| +12% | +$571K | 1.06% | 21 |
|
|
2019
Q4 | $7.82M | Sell |
143,717
-20,202
| -12% | -$1.1M | 0.81% | 19 |
|
|
2019
Q3 | $6.84M | Buy |
163,919
+1,361
| +0.8% | +$56.8K | 0.58% | 49 |
|
|
2019
Q2 | $7.12M | Buy |
162,558
+54,516
| +50% | +$2.39M | 0.65% | 45 |
|
|
2019
Q1 | $5.56M | Buy |
108,042
+4,432
| +4% | +$228K | 0.5% | 53 |
|
|
2018
Q4 | $3.83M | Buy |
103,610
+16,596
| +19% | +$614K | 0.41% | 87 |
|
|
2018
Q3 | $3.27M | Sell |
87,014
-532
| -0.6% | -$20K | 0.26% | 151 |
|
|
2018
Q2 | $3.46M | Sell |
87,546
-693
| -0.8% | -$27.4K | 0.24% | 136 |
|
|
2018
Q1 | $2.27M | Buy |
+88,239
| New | +$2.27M | 0.16% | 182 |
|
|
2017
Q4 | – | Sell |
-96,367
| Closed | -$3.6M | – | 294 |
|
|
2017
Q3 | $3.6M | Buy |
96,367
+149
| +0.2% | +$5.57K | 0.25% | 133 |
|
|
2017
Q2 | $2.41M | Buy |
+96,218
| New | +$2.41M | 0.17% | 194 |
|